Relapse in stage I(E) diffuse large B‐cell lymphoma

Despite a general favourable outcome in limited stage diffuse large B‐cell lymphoma (DLBCL), relapses occur in about 10 to 20% of patients. Prognostic models only partially identify patients at risk for relapse. Moreover, it is not known whether the outcome after such a relapse is similar to the out...

Descripción completa

Detalles Bibliográficos
Autores principales: Nijland, Marcel, Boslooper, Karin, van Imhoff, Gustaaf, Kibbelaar, Robbie, Joosten, Peter, Storm, Huib, van Roon, Eric N., Diepstra, Arjan, Kluin‐Nelemans, Hanneke C., Hoogendoorn, Mels
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947732/
https://www.ncbi.nlm.nih.gov/pubmed/29083044
http://dx.doi.org/10.1002/hon.2487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947732/
https://www.ncbi.nlm.nih.gov/pubmed/29083044
http://dx.doi.org/10.1002/hon.2487

Ejemplares similares